Company Profiles

driven by the PitchBook Platform

Allosteros Therapeutics

Description

Developer of drugs targeting unique sites on key proteins in cardiovascular disease signaling pathways. The company engages itself in the development of small molecule drugs that target allosteric sites on key proteins in disease pathways.

2009

Founded

PRIVATE

Status

Grant

Latest Deal Type

$249k

Latest Deal Amount

$1.32M

Total Amount Raised

3

Investors

Description

Developer of drugs targeting unique sites on key proteins in cardiovascular disease signaling pathways. The company engages itself in the development of small molecule drugs that target allosteric sites on key proteins in disease pathways.

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Primary Office

560 Pena Court Palo Alto, CA 94306United States +1 (650) 812-3475
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Allosteros Therapeutics's full profile, request a free trial.

Allosteros Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Allosteros Therapeutics Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Broadview VenturesVenture CapitalMinority000 0000000 0000
National Institutes of HealthGovernment000 0000000 0000
U.S. Department of Health and Human ServicesGovernment000 0000000 0000
Broadview Ventures Venture Capital
National Institutes of Health Government
U.S. Department of Health and Human Services Government

Allosteros Therapeutics Executive Team (1)

NameTitleBoard
Seat
Contact
Info
Howard Schulman Ph.DPresident & Chief Scientific Officer
Howard Schulman Ph.D President & Chief Scientific Officer

Allosteros Therapeutics Board Members (1)

NameRepresentingRoleSinceContact
Info
Christopher De Souza Ph.DBroadview VenturesDirector000 0000
Christopher De Souza Ph.D Director Broadview Ventures
Request full access to PitchBook